69 related articles for article (PubMed ID: 10408398)
21. Mutation of FADD gene is rare in human colon and stomach cancers.
Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2004 Sep; 112(9):595-7. PubMed ID: 15601308
[TBL] [Abstract][Full Text] [Related]
22. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of ETV6 in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
[TBL] [Abstract][Full Text] [Related]
24. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
25. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
26. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the kinase domain of MYLK2 gene in common human cancers.
Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
Pathol Res Pract; 2006; 202(3):137-40. PubMed ID: 16448786
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the BCL10 gene in childhood solid malignancies.
Miao J; Kusafuka T; Udatsu Y; Okada A
Med Pediatr Oncol; 2002 Dec; 39(6):543-6. PubMed ID: 12376974
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the ARAF gene in human cancers.
Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Min WS; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2005 Jan; 113(1):54-7. PubMed ID: 15676015
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of PTPRT phosphatase domains in common human cancers.
Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
33. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
34. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
35. Absence of ST7 gene alterations in human cancer.
Dong SM; Sidransky D
Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
[TBL] [Abstract][Full Text] [Related]
36. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
37. Normal polymorphism in the incomplete trinucleotide repeat of the arginine-rich protein gene.
Evron E; Cairns P; Halachmi N; Ahrendt SA; Reed AL; Sidransky D
Cancer Res; 1997 Jul; 57(14):2888-9. PubMed ID: 9230196
[TBL] [Abstract][Full Text] [Related]
38. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
39. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract][Full Text] [Related]
40. Bcl10 mutations in malignancy.
Dyer MJ
Br J Cancer; 1999 Jul; 80(10):1491. PubMed ID: 10408386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
